MeiraGTx (MGTX) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
First Tracks Biotherapeutics is the larger company by market cap ($1.11 billion vs $1.02 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MGTX | TRAX |
|---|---|---|
| Share price | $10.63 | $30.98 |
| Market cap | $1.02B | $1.11B |
| 1-day change | -1.76% | +1.28% |
| YTD return | +36.10% | — |
| 1-year return | +27.44% | — |
| 5-year return | -24.23% | — |
| P/E ratio (TTM) | 12.22 | — |
| EPS (TTM) | $0.87 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.35 | $49.91 |
| 52-week low | $6.62 | $14.72 |
| Distance from 52-week high | -30.75% | -37.93% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +161.05% | +125.95% |
| Average volume | 797.37K | 785.86K |
| Shares outstanding | 96.04M | 35.73M |
| Employees | 393 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About MeiraGTx
MGTX stock →MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 393 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
MGTX vs TRAX FAQ
Which is bigger, MeiraGTx or First Tracks Biotherapeutics?
First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.11B compared with $1.02B for MeiraGTx (MGTX).
Are MeiraGTx and First Tracks Biotherapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for MeiraGTx and Biotechnology: Pharmaceutical Preparations for First Tracks Biotherapeutics.